GOLDSTEIN DOV A MD
SEC CIK 1120478 · EDGAR
BoughtSold
Most active insiders at BIOA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fortney Kristen | CEO, Dir | — | $4.22M |
| 2 | Barton Shane | Principal Accounting Off | — | $1.58M |
| 3 | RUBIN PAUL D | Chief Medical Off | — | $1.46M |
| 4 | GOLDSTEIN DOV A MD | CFO | — | $531.8K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 16:19 | 2026-04-23 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 36.6K | +11% | +$15.5K |
| D | 2026-03-03 | 2026-03-01 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 33.0K | +12% | +$15.5K |
| D | 2026-02-03 | 2026-02-01 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,541 | 29.5K | +14% | +$15.5K |
| D | 2026-01-21 | 2026-01-16 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 25.9K | +16% | +$15.5K |
| DM | 2026-01-15 | 2026-01-13 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | S - Sale+OE | $19.70 | -27.0K | 40.4K | -40% | -$531.8K |
| D | 2026-01-15 | 2026-01-13 | BIOA | BioAge Labs, Inc. | GOLDSTEIN DOV A MD | CFO | M - OptEx | $8.39 | +27.0K | 49.4K | +120% | +$226.5K |
| D | 2025-08-19 | 2025-08-18 | COYA | Coya Therapeutics, Inc. | GOLDSTEIN DOV A MD | Dir | M - OptEx | $1.09 | +17.6K | 27.6K | +176% | +$19.1K |
| D | 2023-01-04 | 2023-01-03 | COYA | Coya Therapeutics, Inc. | GOLDSTEIN DOV A MD | Dir | P - Purchase | — | +10.0K | 10.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations